Navigation Links
Promising Therapy for Prostate Cancer
Date:6/22/2009

Experimental drug beat back inoperable cancer in two patients, study claims

MONDAY, June 22 (HealthDay News) -- An experimental drug therapy appears to have helped destroy allegedly inoperable prostate cancer in two patients in a clinical trial.

Use of the immunotherapeutic agent MDX-010, or ipilimumab, in combination with standard hormone and radiation treatments helped eliminate the aggressive tumors, which had already spread into the patients' abdominal areas, according to a report from Mayo Clinic researchers that appears in Discovery's Edge, the Mayo Clinic's online research magazine. Both patients are now considered cancer-free.

"The tumors had shrunk dramatically," co-investigator Dr. Michael Blute, a Mayo urologist and surgeon who operated on both patients, said in a Mayo Clinic news release. "I had never seen anything like this before. I had a hard time finding the cancer. At one point, the pathologist [who was working during surgery] asked if we were sending him samples from the same patient."

Ipilimumab is an antibody that appears to greatly magnify the cancer-killing action of androgen ablation, a hormone therapy that helps shrink prostate cancer by eliminating testosterone from the body. Following the additional treatment, the patients showed steady decreases in their prostate-specific antigen (PSA) counts, a test used to detect prostate cancer, and were deemed eligible for surgery. After surgery, one patient underwent additional radiation therapy.

"This is one of the Holy Grails of prostate cancer research," clinical trial leader Dr. Eugene Kwon, a Mayo Clinic urologist, said of the antibody therapy in the same news release.

The team plans more research into how ipilimumab works and how to optimize its use.

More information

The American Cancer Society has more about '/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

1

GOOD

Page: 1 2

Related medicine news :

1. Promising drug combination may help those with ocular melanoma that has spread
2. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
3. Molecule Promising Against Huntingtons Disease
4. Computerized training of working memory is a promising therapeutic strategy in ADHD
5. Baicalin might be a promising therapeutic tool for severe acute pancreatitis
6. Initial Evaluation of New Nucleus Removal Device Provides Promising Results
7. Promising new TB drug given special status by US and European regulators
8. New Drug Promising Against Tough-to-Treat Kidney Cancer
9. Einstein scientists treat cancer as an infectious disease -- with promising results
10. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
11. Protalix BioTherapeutics prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Promising Therapy for Prostate Cancer
Promising Therapy for Prostate Cancer
(Date:7/29/2010)... from researchers at Massachusetts General Hospital and University ... linkage between elevated intrinsic (resting-state) brain connectivity and ... This research shows an interaction of multiple ... arises. Details of the study appear online and ... Rheumatism , a journal published by Wiley-Blackwell on ...
(Date:7/29/2010)... first time a cell-of-origin for human prostate cancer, ... and diagnostics tools and the development of new ... , The researchers, from UCLA,s Jonsson Comprehensive Cancer ... prostate tissue could become human prostate cancer in ... bucks conventional wisdom. It had been widely believed ...
(Date:7/29/2010)... N.Y. -- Hockey fans likely would assume that body-checking ... causes the most injuries in youth ice hockey. But ... study, the largest and most comprehensive analysis to date ... overall injuries were caused by accidentally hitting the boards ... by a puck. , Only 34 percent of the ...
(Date:7/29/2010)... after publishing the mnemonic "ABCD" to facilitate the early ... that moniker says early detection remains a key factor ... M.D. and colleagues from the Ronald O. Perelman Department ... say that, despite all of the advances in melanoma ... remain critical. Their report appears online on CA First ...
(Date:7/29/2010)... Amanda Gardner HealthDay Reporter , , WEDNESDAY, July 28 ... able to grow an entire joint from stem cells, albeit ... rabbits were able to hop and walk and bear weight, ... of a paper published online July 29 in The ... joint with restored functioning." If replicated in humans, the ...
Breaking Medicine News(10 mins):Health News:Resting brain activity associated with spontaneous fibromyalgia pain 2Health News:UCLA scientists for the first time identify a cell-of-origin for human prostate cancer 2Health News:UCLA scientists for the first time identify a cell-of-origin for human prostate cancer 3Health News:Most youth hockey injuries caused by accidents, not checking, UB study shows 2Health News:The evolution of melanoma diagnosis: 25 years beyond the ABCDs 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 3
... University of Pittsburgh-led team has used gene technology to breed animals ... pigs and they had a key gene inserted in them. // ... that had the capability to produce compounds useful for the heart. ... have a similar physiology. We could use these animals as a ...
... new study has found that attempting of suicide is high ... // ,Researchers from the University of British Columbia ... 30,000 men - who were working or had worked at ... portal EurekAlert. ,They collected data on the ...
... twice as likely to die between the ages of 30 and ... for Public Health and Nursing Research at the University of Bremen ... greater readiness to take health risks and their more dangerous working ... and a sixth of women, drink too much alcohol, the study ...
... discrimination against the people suffering from AIDS, Satyam Computer ... // ,Satyam is the first Indian IT ... selected for jobs in its various software development centres ... conducting the HIV/AIDS test to protect employees from discrimination ...
... Recent estimates of deaths from breathing smog are revealed ... the Los Angeles Basin. // ,Unlike ... of preventive medicine, measured specific amounts of soot and ... citywide averages. ,Mortality from heart attacks and ...
... in Norwich is a non-referral drop-in-center aimed at people, who ... its fallen apart. // Founded in 1994, the centre is ... health charity Rethink. The centre will be launching an initiative ... shallowness, that follows mental illness. ,The place is meant ...
Other Medicine News:Health News:Satyam Stops Conducting HIV Tests On Employees To Prevent Discrimination 2Health News:Death by Smog in California 2Health News:Bridging People’s lives, Post Upheava 2
(Date:7/28/2010)... Matrixx Initiatives, Inc. (Nasdaq: MTXX ), an over-the-counter ... first quarter ended June 30, 2010 , will be released ... An earnings conference call will be held the following morning on ... . , , , ... access the teleconference, please call (888) 287-5536 (domestic) or (719) 325-2332 ...
(Date:7/28/2010)... DURECT Corporation (Nasdaq: DRRX ) announced today that ... Capital Markets 10th Annual Focus on Healthcare Conference on Thursday, August 5 ... at the Sheraton New York Hotel.   , ... (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO ) , , ... http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) , , , ...
(Date:7/28/2010)... , July 28 Dr. Michael Klein , ... how FDA works with other entities to confront and to prevent misuse ... , , ... , , ... , , ...
Breaking Medicine Technology:Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 First Quarter Financial Results 2DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference 2FDA CONSUMER HEALTH INFORMATION - Combating Misuse and Abuse of Prescription Drugs: Q&A with Michael Klein, Ph.D. 2Information about the use and accuracy of breast cancer tests is lacking study finds 56994 1Information about the use and accuracy of breast cancer tests is lacking study finds 56994 2Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 1Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 2Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 3Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 4Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 5Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 6Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 1Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 2Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 3Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 4Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 5
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens...
The Multi-Purpose Stand Magnifier is the most versatile stand magnifier. The stand has multiple configurations allowing for all situations where hands-free magnification is needed....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Bausch & Lomb round and rectangular magnifiers incorporate precision optics and an ergonomic design for increased clarity and comfort during use...
Medicine Products: